DGAP-News

MeVis Medical Solutions AG: MeVis' profitability further increased in the first quarter - Seite 2

account lower income tax expenses of EUR 106 k MeVis closed the first
quarter of the current financial year with a consolidated net profit of EUR
802 k (prev. year: EUR 108 k). Thus earnings per share amount to EUR 0.47
(prev. year: EUR 0.06).

Liquid funds remained stable in the reporting period and amounted to EUR
8,622 k on March 31, 2013 (December 31, 2012: EUR 8,665 k).

'On account of business development in the first three months of 2013, we
confirm our forecast for the current fiscal year, which expected sales in
2013 to be down slightly on the 2012 fiscal year. In our opinion the
consolidated earnings before interest and taxes (EBIT) is mainly influenced
the expected slight drop in sales, the lower level of capitalized
development expenses and the again slight reduction in personnel expenses.
Overall, we expect EBIT to decline slightly.' says Dr. Robert Hannemann,
CFO of MeVis Medical Solutions AG. 'In addition, we expect a positive cash
flow again in 2013, where in addition to the ongoing business the reduction
in trade receivables should make a significant contribution.'

'We now focus on the development and implementation of measures to generate
future sales growth so as to offset the trend of a declining new license
business.' added Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. 'The
expansion of business relationships with existing industrial customers is
showing initial signs of success, which are expected to materialize into
small contributions to sales in the second half of the year. We have also
had initial talks with potential new industrial customers to gain
additional customers in our core business of selling software licenses and
therefore to modify and expand our product portfolio to meet the needs of
our customers. In order to build up the business with Internet-based
services, we will launch initial services on the market this year and
gradually expand these services. '

The financial reports of the company can be downloaded here:
http://www.mevis.de/ir_finanzberichte.html


End of Corporate News

---------------------------------------------------------------------

16.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
211352 16.05.2013